Reuters reported on November 5 that India could launch Covaxin as early as February 2021. Covaxin is the vaccine candidate developed by Bharat Biotech and backed by Indian Council of Medical Research.
Meanwhile, Peru and Chile will soon begin trials for the vaccine developed by University of Oxford and AstraZeneca.
Tune in to Coronavirus Essential podcast with Sakshi Batra for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!